Incyte price target raised to $88 from $86 at TD Cowen
TD Cowen analyst Marc Frahm raised the firm’s price target on Incyte (INCY) to $88 from $86 and keeps a Buy rating on the shares. The firm said ...
Incyte terminates license agreement with Agenus
Agenus (AGEN) entered into a License, Development, and Commercialization Agreement with Incyte (INCY), under which Incyte ...
Incyte Corp. stock underperforms Monday when compared to competitors
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Incyte Corp. stock underperforms Friday when compared to competitors
Shares of Incyte Corp. INCY slid 1.09% to $74.13 Friday, on what proved to be an all-around poor trading session for the ...
AZOM4 天
Bruker Launches the VERTEX NEO Platform
Bruker Corporation today announced the launch of the VERTEX NEO Platform today with its first product, the VERTEX NEO R. This ...